Acrivon Therapeutics, Inc. Common StockACRVNASDAQ
Loading
Expenses from normal business operations (SG&A, R&D, etc.)
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $84.11M | -4.6% |
| 2024 | $88.19M | +32.2% |
| 2023 | $66.70M | +104.2% |
| 2022 | $32.66M | +101.8% |
| 2021 | $16.18M | +410.9% |
| 2020 | $3.17M | - |